You just read:

RegeneRx Joint Venture to Begin Second Phase 3 Study Of RGN-259 for Dry Eye Syndrome in 3rd Quarter

News provided by

RegeneRx Biopharmaceuticals, Inc.

24 Aug, 2016, 08:00 ET